KelSie Biotech Corp — Form D
KelSie Biotech Corp of ENGLEWOOD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-02. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-04-02
- Form: D
- Accession: 0001778644-21-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.3M
- Remaining: $654K
- Investors: 16
- Date of first sale: 2021-03-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-394588
Issuer
- Name: KelSie Biotech Corp
- CIK: 0001778644
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3465 S GAYLORD COURT, SUITE A316, ENGLEWOOD, CO, 80113
- Phone: 303-468-2576
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Michael F Gruber | Director | Englewood, CO |
| Jeffrey F Howard | Director | Englewood, CO |
| Ben Kaanta | Director | Englewood, CO |
| Cameron F Keluche | Director | Englewood, CO |
| Linda F Sonntag | Director | Englewood, CO |
| Ben Kaanta | Executive Officer | Englewood, CO |
| Cameron F Keluche | Executive Officer | Englewood, CO |
| WILLIAM J GREEN | Director | MILL VALLEY, CA |
| Christie F Spencer | Executive Officer | Englewood, CO |
| Jeffrey J Howard | Director | Englewood, CO |
| Linda S Sonntag | Director | Englewood, CO |
| Michael J Gruber | Director | Seattle, WA |
Other filings by this issuer (1)
More